Coexistent of Morphea and DLE in a Patient With Beta Thalassemia Leading to a Diagnosis of Systemic Lupus Erythematous

Marilyn Le, Payvand Kamrani, L. Claire Hollins

Research output: Contribution to journalArticlepeer-review

Abstract

Patients with autoimmune disorders are predisposed to developing a second autoimmune condition. This can be applied to cutaneous conditions as well. Morphea or localized scleroderma is an autoimmune inflammatory and fibrosing skin disorder due to increased collagen deposition.1,2 Patients with morphea are four times likelier of having a concomitant autoimmune disease.1 There have been cases of systemic lupus erythematosus (SLE) with morphea, but the co-occurrence of discoid lupus erythematosus (DLE) with morphea has been rarely reported, and never reported in patient with Beta-thalamessmia.1,2,7 Morphea and discoid lupus erythematosus can be found within one lesion or as separate diagnoses. In this case, we describe a patient with morphea and discoid lupus erythematous in the setting of beta thalassemia leading to diagnosis of SLE.

Original languageEnglish (US)
Pages (from-to)243-245
Number of pages3
JournalSKIN: Journal of Cutaneous Medicine
Volume6
Issue number3
DOIs
StatePublished - May 6 2022

All Science Journal Classification (ASJC) codes

  • Dermatology

Fingerprint

Dive into the research topics of 'Coexistent of Morphea and DLE in a Patient With Beta Thalassemia Leading to a Diagnosis of Systemic Lupus Erythematous'. Together they form a unique fingerprint.

Cite this